Sana Biotechnology Inc logo

Sana Biotechnology Inc

$ 6.72 -0.49 (-6.8%) 04:00 PM EST
P/E:
At Loss
P/B:
1.84
Market Cap:
$ 1.19B
Enterprise V:
$ 1.00B
Volume:
4.58M
Avg Vol (2M):
1.52M
Volume:
4.58M
Market Cap $:
1.19B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.52M
Enterprise Value $:
1.00B
PB Ratio:
1.84
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Sana Biotechnology Inc
NAICS : 541714 SIC : 2833
188 East Blaine Street, Suite 400, Seattle, WA, USA, 98102
Description
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring technology, organizing and staffing the Company, business planning, establishing the company's intellectual property portfolio, raising capital, and providing general and administrative support for these operations.
Name Current Vs Industry Vs History
Cash-To-Debt 4.27
Equity-to-Asset 0.66
Debt-to-Equity 0.18
Debt-to-EBITDA -0.4
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 28.72
9-Day RSI 41.13
14-Day RSI 46.27
6-1 Month Momentum % 21.66
12-1 Month Momentum % -64.05

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.09
Quick Ratio 5.09
Cash Ratio 4.99

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -39.14
ROA % -26.41
ROIC % -52.51
ROC (Joel Greenblatt) % -196.48
ROCE % -28.69

Financials (Next Earnings Date:2022-11-08 Est.)

SANA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:SANA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.62
Beta 0
Volatility % 91.5
14-Day RSI 46.27
14-Day ATR ($) 0.691489
20-Day SMA ($) 7.57
12-1 Month Momentum % -64.05
52-Week Range ($) 3.925 - 26.6
Shares Outstanding (Mil) 190.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sana Biotechnology Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More